CLINICAL AND SUBCLINICAL CHARACTERISTICS AND SOME FACTORS RELATED TO DISEASE ACTIVITY INDEX IN PATIENTS WITH PSORIATIC ARTHRITIS

Thị Lệ Thủy Nguyễn, Đình Tùng Lê, Hữu Nghị Đinh

Main Article Content

Abstract

Objective: Psoriatic arthritis (PSO) is a chronic inflammatory arthritis that often occurs in patients with psoriasis. The clinical and subclinical characteristics are different from joint diseases such as rheumatoid arthritis, ankylosing spondylitis... leading to difficulties in diagnosis and treatment. The objective of the study is to evaluate the above characteristics and some factors related to disease activity index in PSO patients. Subjects and methods: Cross-sectional, retrospective descriptive study conducted on 62 patients with a confirmed diagnosis of PSO who came for examination or treatment at the National Hospital of Dermatology and Venereology from October 2023 to June 2024. Patients who meet the disease selection criteria have information collected about general, clinical, paraclinical characteristics, DAPSA, VAS, PASI, NASI index. Evaluate the relationship between the above characteristics and disease activity level according to DAPSA and VAS index. Results: Mean age is 50,7; Male/female ratio is approximately 2/1. Mean disease duration is 5,8 years. Pain is the most common clinical symptom (92.1%), followed by joint swelling (59.6%); limited mobility (48.3%) and stiffness (45.2%). Most cases manifest in isolated peripheral joints. The average number of damaged joints is 12 joints/patient. The mean DAPSA and mean VAS scores were 25.3 and 5.4, respectively. Most blood tests are within normal limits. Long disease duration is a factor that increases the rate of moderate/severe DAPSA in the study group. Conclusion: Joint pain is the most common clinical symptom. The research team's CRP test was high, while other blood tests were often within normal limits. Long disease duration increases the rate of moderate-severe disease activity.

Article Details

References

1. Quỳnh NT, Liễu LT, Thủy NTP. Nghiên cứu đặc điểm lâm sàng, hình ảnh siêu âm các khớp ngoại vi trong bệnh viêm khớp vẩy nến. Tạp Chí Học Việt Nam. 2023;532(2). doi:10.51298/ vmj.v532i2.7590
2. Vinh NM, Vân BT. Nghiên cứu hiệu quả điều trị, tính an toàn và khả năng dung nạp của methotrexate trong điều trị viêm khớp vảy nến. J 108 - Clin Med Phamarcy. Published online February 12, 2018. Accessed June 12, 2024. https://tcydls108.benhvien108.vn/index.php/YDLS/article/view/231
3. Amer AS, Al Shambaky AY, Ameen SG, Sobih AK. Hematological indices in psoriatic enthesopathy: relation to clinical and ultrasound evaluation. Clin Rheumatol. 2024;43(6):1909-1917. doi:10.1007/s10067-024-06951-2
4. Gottlieb AB, Merola JF, Reich K, et al. Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate‐to‐severe plaque psoriasis: results from EXCEED, a randomized, double‐blind head‐to‐head monotherapy study. Br J Dermatol. 2021;185(6):1124-1134. doi:10.1111/bjd.20413
5. Lubrano E, Scriffignano S, Fatica M, et al. Psoriatic Arthritis in Males and Females: Differences and Similarities. Rheumatol Ther. 2023; 10(3):589-599. doi:10.1007/s40744-023-00535-3
6. Nguyễn Thu Hương. Đánh giá kết quả điều trị bệnh viêm khớp vẩy nến bằng secukinumab sau 12 tuần điều trị. Published online 2020.
7. Balevi A, Olmuşçelik O, Ustuner P, Özdemir M. Is there any Correlation between Red Cell Distribution Width, Mean Platelet Volume Neutrophil Count, Lymphocyte Count, and Psoriasis Area Severity Index in Patients Under Treatment for Psoriasis? Acta Dermatovenerol Croat ADC. 2018;26(3):199-205.
8. FitzGerald O, Haroon M, Giles JT, Winchester R. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015;17(1):115. doi:10.1186/s13075-015-0640-3